What's happening
This bill repeals the excise tax on medical cannabis and eliminates the medical cannabis trust fund in New York.
Why it matters
Reduces Costs for Patients. Eliminating the excise tax on medical cannabis could lower out-of-pocket costs for patients who rely on cannabis for medical treatment, making it more financially accessible.
Potential to Increase Medical Cannabis Use. With reduced financial barriers, more patients may be encouraged to seek medical cannabis as an alternative therapy, potentially improving patient outcomes for those with qualifying conditions.
Changes in State Revenue and Spending. The repeal of both the tax and the medical cannabis trust fund means the state will no longer collect dedicated revenue from medical cannabis sales or earmark those funds for specific purposes, which could impact programs previously supported by the trust fund or shift fiscal priorities.
Signals a Shift in Cannabis Policy. This move may indicate a broader trend toward normalizing medical cannabis and aligning its taxation more closely with other prescription medications, reflecting changing attitudes about its use and regulation.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
End Medical Cannabis Tax
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 56
History
- Referred to budget and revenue
- Referred to budget and revenue
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Medical Cannabis Tax
In Assembly Committee · Ways And Means · Sponsor Crystal Peoples-Stokes
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5365
2023-2024 Regular Sessions
IN SENATE
March 2, 2023
Introduced by Sens. COONEY, SCARCELLA-SPANTON -- read twice and ordered printed, and when printed to be committed to the Committee on Budget and Revenue
AN ACT to repeal section 490 of the tax law relating to the excise tax on medical cannabis; and to repeal section 89-h of the state finance law relating to the medical cannabis trust fund
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 490 of the tax law is REPEALED.
§ 2. Section 89-h of the state finance law is REPEALED.
§ 3. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09877-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to repeal section 490 of the tax law relating to the excise tax on medical cannabis; and to repeal section 89-h of the state finance law relating to the medical cannabis trust fund
Summary of provisions
Section 1 repeals section 490 of the tax law.
Section 2 repeals section 89-h of the state finance law.
Section 3 is the effective date.
Justification
New York State currently has one of the highest tax rates on medical cannabis in the nation. Bordering states, including Connecticut, Massa- chusetts, New Jersey, Rhode Island, and Vermont have no excise tax on medical cannabis products whatsoever. All except Rhode island have lower total rates, including 0% total in Massachusetts and 2% in New Jersey. This, combined with the administrative hurdles to obtaining a medical card and the limited number of dispensaries, serve to restrict patient access across the state, especially for economically disadvantaged New Yorkers.
Medical cannabis has been shown to provide critical benefits to New Yorkers. A recent DOH report found that patients receiving 30 days or more of medical cannabis for chronic pain is associated with a reduction in the use of prescription opioids by up to 51%. Medical cannabis is well-known to relieve symptoms for individuals suffering from Multiple Sclerosis and other nerve pain. Medical cannabis is also a popular tool for individuals undergoing chemotherapy for cancer treatment.
Because the program is currently so limited due to cost and administra- tive hurdles, state tax revenues from the program are minimal. In FY22, the entire program generated $12.9M in tax revenue. Medical dispensar- ies first opened in January 2016. It is far past time to make necessary improvements to this program for the good of patients across New York State.
New York currently trails 27 other U.S. States in terms of medical patient enrollment per capita, which shows that changes are necessary to establish a robust medical cannabis program. This bill, by repealing the 7% excise tax on medical cannabis products, will ensure equitable patient access to the products they need for health purposes.
Legislative history
This is a new bill.
Fiscal implications
To be determined
Effective date
This act shall take effect immediately
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.